RARITAN, N.J., March 23, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it received authorization ...
* ORTHO CLINICAL DIAGNOSTICS SAYS ORTHO'S TOTAL ANTIBODY TEST FOR COVID-19 RECEIVES EMERGENCY USE AUTHORIZATION FROM FDA Source text for Eikon: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback